We are live on ! Find out more
RLYB icon

Rallybio
RLYB

66 hedge funds and large institutions have $42.4M invested in Rallybio in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 17

6% more funds holding

Funds holding: 62 → 66 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.44% less ownership

Funds ownership: 9.98% → 9.54% (-0.44%)

24% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 17

24% less capital invested

Capital invested by funds: $55.9M → $42.4M (-$13.5M)

Holders
66
Holders Change
+4
Holders Change %
+6.45%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
13
Reduced
17
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JJ
Johnson & Johnson
New Jersey
+$6.16M
2
Millennium Management
Millennium Management
New York
+$446K
3
Goldman Sachs
Goldman Sachs
New York
+$285K
4
AC
Almitas Capital
California
+$171K
5
YIH
Y-Intercept (HK)
Hong Kong
+$160K

Top Sellers

1
BlackRock
BlackRock
New York
-$2.3M
2
State Street
State Street
Massachusetts
-$760K
3
BOCH
Blue Owl Capital Holdings
New York
-$648K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$508K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$371K
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$5.62M – – –
JJ
2
Johnson & Johnson
New Jersey
$4.87M +$6.16M +454,545 New
5VM
3
5AM Venture Management
California
$4.87M – – –
NLVP
4
New Leaf Venture Partners
New York
$4.42M – – –
TGA
5
TPG GP A
Texas
$4.06M – – –
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$3.22M – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$3.07M +$17.7K +1,305 +0.5%
CPX
8
Canaan Partners XI
California
$2.76M – – –
Aberdeen Group
9
Aberdeen Group
United Kingdom
$2.31M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$1.15M -$371K -27,359 -20%
LCM
11
Laurion Capital Management
New York
$1.05M – – –
Millennium Management
12
Millennium Management
New York
$616K +$446K +32,899 +134%
Mariner
13
Mariner
Kansas
$544K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$457K -$250K -18,425 -30%
BlackRock
15
BlackRock
New York
$423K -$2.3M -170,043 -81%
Citadel Advisors
16
Citadel Advisors
Florida
$375K -$203K -14,958 -30%
Northern Trust
17
Northern Trust
Illinois
$307K -$26.9K -1,982 -6%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$295K -$508K -37,455 -58%
Goldman Sachs
19
Goldman Sachs
New York
$243K +$285K +20,995 +1,269%
AC
20
Almitas Capital
California
$135K +$171K +12,610 New
BCM
21
Bridgeway Capital Management
Texas
$129K – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$129K +$138K +10,191 +559%
YIH
23
Y-Intercept (HK)
Hong Kong
$127K +$160K +11,811 New
CC
24
Centiva Capital
New York
$96.1K +$121K +8,963 New
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$89K +$61.7K +4,550 +116%
1
2 3 4

RLYB Hedge Fund Activity: Q2 2024 in Review

66 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q2 2024, worth a combined $42.4M — down 24% from $55.9M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RLYB positions and 17 closed out — a net gain of 4 holders — while 13 added to existing stakes and 17 trimmed.

The largest buyer was Johnson & Johnson, opening a new position worth an estimated $6.16M. The largest seller was BlackRock, cutting an estimated $2.3M.

  • 66 institutional investors held Rallybio (RLYB) as of Q2 2024, up from 62 in Q1 2024.
  • Funds reported $42.4M of Rallybio stock for Q2 2024, down 24% quarter-over-quarter.
  • 21 funds opened new Rallybio positions in Q2 2024 and 17 closed out, a net change of +4 holders.
  • The largest Rallybio buyer in Q2 2024 was Johnson & Johnson, an estimated $6.16M added.
  • The largest Rallybio seller in Q2 2024 was BlackRock, an estimated $2.3M sold.

Based on aggregated 13F filings for Q2 2024.